Frankfurt - Delayed Quote EUR

Fresenius SE & Co. KGaA (FRE.F)

36.27

+0.07

+(0.19%)

As of 11:39:35 AM GMT+2. Market Open.

Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock?

Delcath Systems (DCTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks 21 hours ago

FRE.DE
The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb

Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb are included in this Analyst Blog.

Zacks yesterday

PCRX

SRPT

EWTX
Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

PCRX and EWTX are in the spotlight this week following important regulatory and pipeline news.

Zacks yesterday

EWTX

PCRX

SRPT
PCRX Stock Soars on Exparel Patent Settlement With Generic Players

Pacira BioSciences stock rises as it settles Exparel patent litigation with several generic players protecting the drug's exclusivity in the United States at least until 2030.

Zacks 2 days ago

FRE.DE

PCRX
Update: Pacira Biosciences Settles Patent Litigations Over Local Analgesic; Shares Rise Pre-bell

(Updates with stock price movement in the first paragraph and headline.) Pacira Biosciences (PCRX

PREMIUM
MT Newswires 3 days ago

FRE.DE
Pacira Biosciences Settles Patent Litigations Over Local Analgesic

Pacira Biosciences (PCRX) said Monday it settled the litigations with Fresenius Kabi USA, Jiangsu He

PREMIUM
MT Newswires 3 days ago

FRE.DE

600276.SS
Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?

Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 7 days ago

NVRO

FRE.DE
Why Fresenius (FMS) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks 9 days ago

FRE.DE
Fresenius SE KGaA Full Year 2024 Earnings: EPS Misses Expectations

Fresenius SE KGaA ( ETR:FRE ) Full Year 2024 Results Key Financial Results Revenue: €21.8b (up 3.6% from FY 2023). Net...

Simply Wall St. 13 days ago

FSNUF

FSNUY
Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?

Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 13 days ago

TNDM

FRE.DE
Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 23 days ago

FRE.DE
Fresenius SE & Co. KGaA's (ETR:FRE) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Fresenius SE KGaA's (ETR:FRE) stock is up by a considerable 16% over the past three months. However, we decided to pay...

Simply Wall St. 25 days ago

FSNUF

FSNUY
Here's Why Fresenius (FMS) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 27 days ago

FRE.DE
Is Alignment Healthcare (ALHC) Stock Outpacing Its Medical Peers This Year?

Here is how Alignment Healthcare (ALHC) and Fresenius (FMS) have performed compared to their sector so far this year.

Zacks 30 days ago

ALHC

FRE.DE
Fresenius Sells Fresenius Medical Care Stake For $1.15 Billion

The healthcare company said it had sold 3.6% of Fresenius Medical Care’s share capital and that it would use the proceeds to help strengthen its balance sheet and reduce leverage.

The Wall Street Journal last month

FSNUF

FSNUY

FMCQF
Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Fresenius SE & Co. KGaA ( ETR:FRE ) saw a decent share price growth of 19% on the XTRA over the last few months. The...

Simply Wall St. last month

FSNUF

FSNUY
Fresenius SE & Co KGaA (FSNUF) Full Year 2024 Earnings Call Highlights: Strong Growth and ...

Fresenius SE & Co KGaA (FSNUF) reports robust financial performance with significant revenue and EBIT growth, while navigating macroeconomic challenges and strategic shifts.

GuruFocus.com last month

FRE.DE
Germany's Fresenius tops profit estimates on strong drug unit performance

German healthcare group Fresenius reported fourth-quarter earnings above market expectations on Wednesday, driven by a strong performance at its hospital drug unit Kabi. Its shares jumped around 7% by 0910 GMT, among top performers on Europe's benchmark STOXX 600 index. Since 2022, Fresenius has been reorganizing its businesses to reduce costs and liabilities, including ceding control of its former dialysis unit, Fresenius Medical Care, and exiting some other non-core operations to focus on Kabi and hospital operator Helios.

Reuters last month

FME.DE

FRE.DE
Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...

Simply Wall St. 2 months ago

FSNUF

FSNUY
Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know

Fresenius (FMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks 3 months ago

FRE.DE

Performance Overview

Return	FRE.F	DAX P (^GDAXI)
YTD	+8.04%	+2.53%
1-Year	+43.19%	+13.69%
3-Year	+12.14%	+43.83%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Fresenius SE & Co. KGaA (FRE.F)

Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock?

The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

PCRX Stock Soars on Exparel Patent Settlement With Generic Players

Update: Pacira Biosciences Settles Patent Litigations Over Local Analgesic; Shares Rise Pre-bell

Pacira Biosciences Settles Patent Litigations Over Local Analgesic

Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

Fresenius SE KGaA Full Year 2024 Earnings: EPS Misses Expectations

Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?

Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term

Fresenius SE & Co. KGaA's (ETR:FRE) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Here's Why Fresenius (FMS) is a Strong Value Stock

Is Alignment Healthcare (ALHC) Stock Outpacing Its Medical Peers This Year?

Fresenius Sells Fresenius Medical Care Stake For $1.15 Billion

Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Fresenius SE & Co KGaA (FSNUF) Full Year 2024 Earnings Call Highlights: Strong Growth and ...

Germany's Fresenius tops profit estimates on strong drug unit performance

Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know

Performance Overview